Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoporosis, Postmenopausal | Phase 3 | US | 05 Aug 2019 |